FDA Details Observations At Stricken Jubilant Roorkee Facility
List Of Seven Form 483 Observations of CGMP Deficiencies Published
Indian firm Jubilant Pharmova demonstrated a host of deficiencies at its manufacturing facility in Roorkee, including for cleanliness, laboratory controls, control procedures and data management, according to a US FDA Form 483 that has just been unveiled.
